+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharming Group NV - logo

The Pharming Group offers novel platforms for the production of protein therapeutics, as well as processes for the purification and formulation. The company’s best known product is Ruconest, a human C1 inhibitor. Human C1 inhibitor is a protein involved in the regulation of the complement and contact pathways of the immune system. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Lactoferrin market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027 - Product Thumbnail Image

Lactoferrin market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

  • Report
  • September 2021
  • 100 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 146 Pages
  • Global
From
Asia Pacific Lactoferrin Market By Function, By Application, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Asia Pacific Lactoferrin Market By Function, By Application, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

  • Report
  • August 2021
  • 84 Pages
  • Asia Pacific
From
Lysosomal Alpha Glucosidase Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Lysosomal Alpha Glucosidase Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • September 2024
  • 91 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 127 Pages
  • Global
From
Ischemia Reperfusion Injury - Pipeline Review, H2 2020 - Product Thumbnail Image

Ischemia Reperfusion Injury - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 197 Pages
  • Global
From
Pharming Group N.V. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Pharming Group N.V. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Pharming Group NV (PHARM) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Pharming Group NV (PHARM) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • June 2024
  • 60 Pages
From
Loading Indicator